These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 31598843)

  • 21. Inhibition of HIV type 1 replication by simultaneous infection of peripheral blood lymphocytes with human immunodeficiency virus types 1 and 2.
    Dern K; Rübsamen-Waigmann H; Unger RE
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):295-309. PubMed ID: 11242517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of L-lysine amino acid on the HIV-1 RNA replication in vitro.
    Butorov EV
    Antivir Chem Chemother; 2015 Feb; 24(1):39-46. PubMed ID: 26149265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific immune response to human immunodeficiency virus (HIV)-1 in patients assessed through the production of interferon-gamma and interleukin-4 in HIV-1 p24-activated whole blood cultures: relationship with the viral load in plasma.
    Hober D; Benyoucef S; Chieux V; De Groote D; De La Tribonnière X; Bocket L; Lion G; Mouton Y; Wattré P
    Scand J Immunol; 1999 Jul; 50(1):83-90. PubMed ID: 10404056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short communication: HIV antigen-specific reactivation of HIV infection from cellular reservoirs: implications in the settings of therapeutic vaccinations.
    Shete A; Thakar M; Singh DP; Gangakhedkar R; Gaikwad A; Pawar J; Paranjape R
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):835-43. PubMed ID: 21936714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure to detect active virus replication in mast cells at various tissue sites of HIV patients by immunohistochemistry.
    Nelson AM; Auerbach A; Man YG
    Int J Biol Sci; 2009 Sep; 5(6):603-10. PubMed ID: 19834544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological and virological markers of disease progression in HIV-infected children.
    Muñoz-Fernández MA; Navarro J; Obregón E; Arias RA; Gurbindo MD; Sampelayo TH; Fernández-Cruz E
    Acta Paediatr Suppl; 1997 Jun; 421():46-51. PubMed ID: 9240857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glutathione inhibits HIV replication by acting at late stages of the virus life cycle.
    Palamara AT; Perno CF; Aquaro S; Buè MC; Dini L; Garaci E
    AIDS Res Hum Retroviruses; 1996 Nov; 12(16):1537-41. PubMed ID: 8911579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The RIAD peptidomimetic inhibits HIV-1 replication in humanized NSG mice.
    Singh M; Singh P; Vaira D; Torheim EA; Rahmouni S; Taskén K; Moutschen M
    Eur J Clin Invest; 2014 Feb; 44(2):146-52. PubMed ID: 24283208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of human immunodeficiency virus type 1 (HIV-1) infection via increased membrane fluidity by a cationic polymer.
    Owada T; Miyashita Y; Motomura T; Onishi M; Yamashita S; Yamamoto N
    Microbiol Immunol; 1998; 42(2):97-107. PubMed ID: 9572041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ozone inactivates HIV at noncytotoxic concentrations.
    Carpendale MT; Freeberg JK
    Antiviral Res; 1991 Oct; 16(3):281-92. PubMed ID: 1805686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Towards a cure for HIV: the identification and characterization of HIV reservoirs in optimally treated people.
    Onafuwa-Nuga A; McNamara LA; Collins KL
    Cell Res; 2010 Nov; 20(11):1185-7. PubMed ID: 20877313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals.
    Ribas SG; Ondoa P; Schüpbach J; van der Groen G; Fransen K
    J Virol Methods; 2003 Oct; 113(1):29-34. PubMed ID: 14500124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy.
    Sarmati L; Nicastri E; Montano M; Dori L; Buonomini AR; d'Ettorre G; Gatti F; Parisi SG; Vullo V; Andreoni M
    J Med Virol; 2004 Apr; 72(4):511-6. PubMed ID: 14981751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of human papillomavirus-associated cells on human immunodeficiency virus gene expression.
    Gage JR; Sandhu AK; Nihira M; Bonecini-Almeida M da G; Cristoforoni P; Kishimoto T; Montz FJ; Martínez-Maza O
    Obstet Gynecol; 2000 Dec; 96(6):879-85. PubMed ID: 11084171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective and anti-human immunodeficiency virus activity of minocycline.
    Zink MC; Uhrlaub J; DeWitt J; Voelker T; Bullock B; Mankowski J; Tarwater P; Clements J; Barber S
    JAMA; 2005 Apr; 293(16):2003-11. PubMed ID: 15855434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
    Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
    AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitory effect of papaverine on HIV replication in vitro.
    Turano A; Scura G; Caruso A; Bonfanti C; Luzzati R; Bassetti D; Manca N
    AIDS Res Hum Retroviruses; 1989 Apr; 5(2):183-92. PubMed ID: 2713167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationships among the detection of p24 antigen, human immunodeficiency virus (HIV) RNA level, CD4 cell count, and disease progression in HIV-infected individuals with hemophilia.
    Sabin CA; Lepri AC; Devereux H; Phillips AN; Loveday C; Lee CA
    J Infect Dis; 2001 Aug; 184(4):511-4. PubMed ID: 11471111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus.
    Chun TW; Justement JS; Moir S; Hallahan CW; Maenza J; Mullins JI; Collier AC; Corey L; Fauci AS
    J Infect Dis; 2007 Jun; 195(12):1762-4. PubMed ID: 17492591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.